Highly efficient constant-current electroporation increases in vivo plasmid expression

DNA and Cell Biology

Volumn 24, Issue 12, 2005, Pages 810-818

  Khan, Amir S ^a   Pope, Melissa A ^a   Draghia Akli, Ruxandra ^a  

^a ADViSYS Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; PLASMID DNA;

AGE; ANIMAL EXPERIMENT; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRIC POTENTIAL; ELECTRIC RESISTANCE; ELECTROPORATION; GENE EXPRESSION; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; SWINE; TECHNIQUE; TISSUE INJURY; TISSUE SPECIFICITY;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ELECTROPORATION; GENE TRANSFER TECHNIQUES; INJECTIONS, INTRAMUSCULAR; MICE; MUSCLE, SKELETAL; PLASMIDS; SUS SCROFA;

ANIMALIA; SUS SCROFA;

EID: 29244460977     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.810     Document Type: Article

References (48)

1. ACSADI, G., DICKSON, G., LOVE, D.R., JANI, A., WALSH, F.S., GURUSINGHE, A., WOLFF, J.A., and DAVIES, K.E. (1991). Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352, 815-818.
2. AIHARA, H., and MIYAZAKI, J. (1998). Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867-870.
3. BABIUK, L.A., PONTAROLLO, R., BABIUK, S., LOEHR, B., and VAN DRUNEN LITTEL-VAN DEN HURK, S. (2003). Induction of immune responses by DNA vaccines in large animals. Vaccine 21, 649-658.
4. BROWN, P.A., DAVIS, W.C., and DRAGHIA-AKLI, R. (2004). Immune enhancing effects of growth hormone releasing hormone delivered by plasmid injection and electroporation. Mol. Ther. 10, 644-651.
5. BUREAU, M.F., NAIMI, S., TORERO, I.R., SEGUIN, J., GEORGER, C., ARNOULD, E., MATON, L., BLANCHE, F., DELAERE, P., and SCHERMAN, D. (2004). Intramuscular plasmid DNA electrotransfer: Biodistribution and degradation. Biochim. Biophys. Acta 1676, 138-148.
6. CAPPELLETTI, M., ZAMPAGLIONE, I., RIZZUTO, G., CILIBERTO, G., MONICA, N.L., and FATTORI, E. (2003). Gene electro-transfer improves transduction by modifying the fate of intramuscular DNA J. Gene Med. 5, 324-332.
7. CHESNOY, S., and HUANG, L. (2002). Enhanced cutaneous gene delivery following intradermal injection of naked DNA in a high ionic strength solution. Mol. Ther. 5, 57-62.
8. DAVALOS, R.V., RUBINSKY, B., and MIR, L.M. (2003). Theoretical analysis of the thermal effects during in vivo tissue electroporation. Bioelectrochemistry 61, 99-107.
9. DRAGHIA-AKLI, R., FIOROTTO, M.L., HILL, L.A., MALONE, P.B., DEAVER, D.R., and SCHWARTZ, R.J. (1999). Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs. Nat. Biotechnol. 17, 1179-1183.
10. DRAGHIA-AKLI, R., KHAN, A.S., CUMMINGS, K.K., PARGHI, D., CARPENTER, R.H., and BROWN, P.A. (2002a). Electrical enhancement of formulated plasmid delivery in animals. Technol. Cancer Res. Treat. 1, 365-371.
11. DRAGHIA-AKLI, R., MALONE, P.B., HILL, L.A., ELLIS, K.M., SCHWARTZ, R.J., and NORDSTROM, J.L. (2002b). Enhanced animal growth via ligand-regulated GHRH myogenic-injectable vectors. FASEB J. 16, 426-428.
12. DRAGHIA-AKLI, R., and SMITH, L.C. (2003). Electrokinetic enhancement of plasmid delivery in vivo. In Gene Therapy-Therapeutic Mechanisms and Strategies. N.S. Templeton and D.D. Lasic, eds. (Marcel Dekker, Inc., New York) pp. 245-263.
13. DURIEUX, A.C., BONNEFOY, R., BUSSO, T., and FREYSSENET, D. (2004). In vivo gene electrotransfer into skeletal muscle: Effects of plasmid DNA on the occurrence and extent of muscle damage. J. Gene Med. 6, 809-816.
14. FEAR, E.C., and STUCHLY, M.A. (1998). Biological cells with gap junctions in low-frequency electric fields. IEEE Trans. Biomed. Eng 45, 856-866.
15. FEWELL, J.G., MACLAUGHLIN, F., MEHTA, V., GONDO, M., NICOL, F., WILSON, E., and SMITH, L.C. (2001). Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol. Ther. 3, 574-583.
16. GEHL, J., and MIR, L.M. (1999). Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem. Biophys. Res. Commun. 261, 377-380.
17. GEHL, J., SKOVSGAARD, T., and MIR, L.M. (1998). Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs. Anticancer Drugs 9:319-325.
18. GEHL, J., SORENSEN, T.H., NIELSEN, K., RASKMARK, P., NIELSEN, S.L., SKOVSGAARD, T., and MIR, L.M. (1999). In vivo electroporation of skeletal muscle: Threshold, efficacy and relation to electric field distribution. Biochim. Biophys. Acta 1428, 233-240.
19. HARTIKKA, J., SUKHU, L., BUCHNER, C., HAZARD, D., BOZOUKOVA, V., MARGALITH, M., NISHIOKA, W.K., WHEELER, C.J., MANTHORP, M., and SAWDEY, M. (2001). Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188. Mol. Ther. 4, 407-415.
20. HEBEL, H.L., ATTRA, H.E., KHAN, A.S., and DRAGHIA-AKLI, R. (2005). Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery device. Vaccine (published online September 5, 2005. PMID: 16150516).
21. HELLER, R., JAROSZESKI, M.J., GLASS, L.F., MESSINA, J.L., RAPAPORT, D.P., DECONTI, R.C., FENSKE, N.A., GILBERT, R.A., MIR, L.M., and REINTGEN, D.S. (1996). Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77, 964-971.
22. KHAN, A.S., SMITH, L.C., ABRUZZESE, R.V., CUMMINGS, K.K., POPE, M.A., BROWN, P.A., and DRAGHIA-AKLI, R. (2003). Optimization of electroporation parameters for the intramuscular delivery of plasmids in pigs. DNA Cell Biol. 22, 807-814.
23. LEE, M.J., CHO, S.S., JANG, H.S., LIN, Y.S., YOU, J.R., PARK, J., SUH, H., KIM, J.A., PARK, J.S., and KIM, D.K. (2002). Optimal salt concentration of vehicle for plasmid DNA enhances gene transfer mediated by electroporation. Exp. Mol. Med. 34, 265-272.
24. LEE, R.C., ZHANG, D., and HANNIG, J. (2000). Biophysical injury mechanisms in electrical shock trauma. Annu. Rev. Biomed. Eng. 2, 477-509.
25. LESBORDES, J.C., BORDET, T., HAASE, G., CASTELNAUPTAKHINE, L., ROUHANI, S., GILGENKRANTZ, H., and KAHN, A. (2002). In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn mice. Hum. Mol. Genet. 11, 1615-1625.
26. LI, S., and MA, Z. (2001). Nonviral gene therapy. Curr. Gene Ther. 1, 201-226.
27. LI, X., EASTMAN, E.M., SCHWARTZ, R.J., and DRAGHIA-AKLI, R. (1999). Synthetic muscle promoters: Activities exceeding naturally occurring regulatory sequences. Nat. Biotechnol. 17, 241-245.
28. LUCAS, M.L., JAROSZESKI, M.J., GILBERT, R., and HELLER, R. (2001). In vivo electroporation using an exponentially enhanced pulse: a new waveform. DNA Cell Biol. 20, 183-188.
29. LUCAS, M.L., HELLER, L., COPPOLA, D., and HELLER, R. (2002). IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol. Ther. 5, 668-675.
30. MARTIN, G.T., PLIQUETT, U.F., and WEAVER, J.C. (2002). Theoretical analysis of localized heating in human skin subjected to high voltage pulses. Bioelectrochemistry 57, 55-64.
31. MATSUBARA, H., GUNJI, Y., MAEDA, T., TASAKI, K., KOIDE, Y., ASANO, T., OCHIAI, T., SAKIYAMA, S., and TAGAWA, M. (2001). Electroporation-mediated transfer of cytokine genes into human esophageal tumors produces anti-tumor effects in mice. Anticancer Res. 21, 2501-2503.
32. MOLNAR, M.J., GILBERT, R., LU, Y., LIU, A.B., GUO, A., LAROCHELLE, N., ORLOPP, K., LOCHMULLER, H., PETROF, B.J., NALBANTOGLU, J., et al. (2004). Factors influencing the efficacy, longevity, and safety of electroporation- assisted plasmid-based gene transfer into mouse muscles. Mol. Ther. 10, 447-455.
33. NEUMANN, E., KAKORIN, S., and TOENSING, K. (1999). Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem. Bioenerg. 48, 3-16.
34. NICOL, F., WONG, M., MACLAUGHLIN, F.C., PERRARD, J., WILSON, E., NORDSTROM, J.L., and SMITH, L.C. (2002). Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation. Gene Ther. 9, 1351-1358.
35. NIEDZINSKI, E.J., CHEN, Y.J., OLSON, D.C., PARKER, E.A., PARK, H., UDOVE, J.A., SCOLLAY, R., MCMAHON, B.M., and BENNETT, M.J. (2003). Enhanced systemic transgene expression after nonviral salivary gland transfection using a novel endonuclease inhibitor/DNA formulation. Gene Ther. 10, 2133-2138.
36. OTTEN, G., SCHAEFER, M., DOE, B., LIU, H., SRIVASTAVA, I., ZUR, M.J., O'HAGAN, D., DONNELLY, J., WIDERA, G., RABUSSAY, D., LEWIS, M.G., et al. (2004). Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 22, 2489-2493.
37. PLIQUETT, U.F., MARTIN, G.T., and WEAVER, J.C. (2002). Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis. Bioelectrochemistry. 57, 65-72.
38. ROY, K., WANG, D., HEDLEY, M.L., and BARMAN, S.P. (2003). Gene delivery with in-situ crosslinking polymer networks generates long-term systemic protein expression. Mol. Ther. 7, 401-408.
39. RUBENSTRUNK, A., MAHFOUDI, A., and SCHERMAN, D. (2004). Delivery of electric pulses for DNA electrotransfer to mouse muscle does not induce the expression of stress related genes. Cell Biol. Toxicol. 20, 25-31.
40. SMITH, L.C., and NORDSTROM, J.L. (2000). Advances in plasmid gene delivery and expression in skeletal muscle. Curr. Opin. Mol. Ther. 2, 150-154.
41. SOMIARI, S., GLASSPOOL-MALONE, J., DRABICK, J.J., GILBERT, R.A., HELLER, R., JAROSZESKI, M.J., and MALONE, R.W. (2000). Theory and in vivo application of electroporative gene delivery. Mol. Ther. 2, 178-187.
42. TERADA, Y., TANAKA, H., OKADO, T., INOSHITA, S., KUWAHARA, M., AKIBA, T., SASAKI, S., and MARUMO, F. (2001). Efficient and ligand-dependent regulated erythropoietin production by naked DNA injection and in vivo electroporation. Am. J Kidney Dis. 38, S50-S53.
43. TONE, C.M., CARDOZA, D.M., CARPENTER, R.H., and DRAGHIA-AKLI, R. (2004). Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs. Cancer Gene Ther. 11, 389-396.
44. VILQUIN, J.T., KENNEL, P.F., PATURNEAU-JOUAS, M., CHAPDELAINE, P., BOISSEL, N., DELAERE, P., TREMBLAY, J.P., SCHERMAN, D., FISZMAN, M.Y., and SCHWARTZ, K. (2001). Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther. 8, 1097-1107.
45. WANG, X.D., TANG, J.G., XIE, X.L., YANG, J.C., LI, S., JI, J.G., and GU J. (2005). A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporation. J. Gene Med. 7, 1235-1245.
46. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
47. WOLFF, J.A., DOWTY, M.E., JIAO, S., REPETTO, G., BERG, R.K., LUDTKE, J.J., WILLIAMS, P., and SLAUTTERBACK, D.B. (1992). Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. J. Cell Sci. 103, 1249-1259.
48. YASUI, A., ODA, K., USUNOMIYA, H., KAKUDO, K., SUZUKI, T., YOSHIDA, T., PARK, H.M., FUKAZAWA, K., and MURAMATSU, T. (2001). Elevated gastrin secretion by in vivo gene electroporation in skeletal muscle. Int. J Mol. Med. 8, 489-494.